Based on 20 years in the specialty medical space, we have cultivated deep relationships with pharmaceutical manufacturers, maxing our access to rebates. We also recognize that no two practice groups are the same. Prescription utilization rates differ from practice to practice, and even from doctor to doctor. At MedProfit, we work with each individual practice group to create and implement a bespoke sell-side rebate collection strategy.
Through its encrypted and confidential data portal, prospective clients provide MedProfit Partners with a sampling of medication and utilization data. This provides us a general understanding of (a) what sell-side rebates might be available to the prospective client, and (b) how much those rebates might be worth over the course of any given 12-month period.
After cataloging and underwriting the prospective client’s utilization data, MedProfit Partners works with its network of Pharmacy Benefits Managers, or Clearinghouses, to identify which drugs are currently offering sell-side rebates and, critically, which Clearinghouse is offering the greatest sell-side rebate.
After structuring a program that optimizes the prospective client’s sell-side rebate return, MedProfit Partners presents that program to the prospective client for review. If the prospective client agrees to adopt the program, it will enter into a Master Services Agreement (MSA) with MedProfit to implement the program on the client’s behalf.
Throughout the life of the MSA, MedProfit Partners will (a) oversee the program’s operation and performance, (b) continuously evaluate and monitor rebate outcomes and formulary effectiveness, and (c) adapt the program’s reach as new sell-side rebates become available or existing ones change so the program continues to deliver the expected value. Through the secured data portal, the client will have real-time audit capabilities of all sell-side rebates delivered through the program.
MedProfit Partners
Copyright © 2024 MedProfit Partners - All Rights Reserved.
Powered by GoDaddy